These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32014514)

  • 41. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.
    Sarfo FS; Nichols M; Agyei B; Singh A; Ennin E; Nyantakyi AD; Asibey SO; Tagge R; Gebregziabher M; Jenkins C; Ovbiagele B
    J Neurol Sci; 2019 Feb; 397():103-111. PubMed ID: 30599299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis.
    Zhu S; Wang W; He J; Duan W; Ma X; Guan H; Wu Y; Li S; Li Y; Tian T; Kong W; Wu D; Zhang T; Huang X
    J Glob Health; 2024 Apr; 14():04078. PubMed ID: 38666515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of antiretroviral therapy switch rate and switching pattern for people living with HIV from a national database in Japan.
    Naito T; Mori H; Fujibayashi K; Fukushima S; Yuda M; Fukui N; Tsukamoto S; Suzuki M; Goto-Hirano K; Kuwatsuru R
    Sci Rep; 2022 Feb; 12(1):1732. PubMed ID: 35110641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing cardiovascular risk in people living with HIV in Asia - where are we now?
    Choi JY; Lui GCY; Liao CT; Yang CJ
    HIV Med; 2022 Feb; 23(2):111-120. PubMed ID: 34494350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
    Grierson J; Koelmeyer RL; Smith A; Pitts M
    HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals.
    Chow FC; Price RW; Hsue PY; Kim AS
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1154-1160. PubMed ID: 28262563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sociodemographic factors affecting viral load suppression among people living with HIV in South Carolina.
    Haider MR; Brown MJ; Harrison S; Yang X; Ingram L; Bhochhibhoya A; Hamilton A; Olatosi B; Li X
    AIDS Care; 2021 Mar; 33(3):290-298. PubMed ID: 31856584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated Eosinophils as a Feature of Inflammation Associated With Hypertension in Virally Suppressed People Living With HIV.
    Masenga SK; Elijovich F; Hamooya BM; Nzala S; Kwenda G; Heimburger DC; Mutale W; Munsaka SM; Zhao S; Koethe JR; Kirabo A
    J Am Heart Assoc; 2020 Feb; 9(4):e011450. PubMed ID: 32064996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda.
    Vecchio A; Robertson K; Saylor D; Nakigozi G; Nakasujja N; Kisakye A; Batte J; Mayanja R; Anok A; Reynolds SJ; Quinn TC; Gray R; Wawer MJ; Sacktor N; Rubin LH
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):534-542. PubMed ID: 32692113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV infection and stroke.
    Benjamin L; Khoo S
    Handb Clin Neurol; 2018; 152():187-200. PubMed ID: 29604976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stroke among highly active antiretroviral therapy-naive people living with the human immunodeficiency virus in China: a retrospective study of the characteristics, risk factors, and prognosis.
    Zhang L; Wang Y; Xu Q; Zhang W; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
    BMC Infect Dis; 2022 Jan; 22(1):4. PubMed ID: 34983408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria.
    Ndembi N; Murtala-Ibrahim F; Tola M; Jumare J; Aliyu A; Alabi P; Mensah C; Abimiku A; Quiñones-Mateu ME; Crowell TA; Rhee SY; Shafer RW; Gupta R; Blattner W; Charurat ME; Dakum P
    AIDS Res Ther; 2020 Nov; 17(1):64. PubMed ID: 33143751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.
    Nance RM; Delaney JAC; Simoni JM; Wilson IB; Mayer KH; Whitney BM; Aunon FM; Safren SA; Mugavero MJ; Mathews WC; Christopoulos KA; Eron JJ; Napravnik S; Moore RD; Rodriguez B; Lau B; Fredericksen RJ; Saag MS; Kitahata MM; Crane HM
    Ann Intern Med; 2018 Sep; 169(6):376-384. PubMed ID: 30140916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.
    Gao L; Xia H; Zeng R; Wu Y; Zaongo SD; Hu Y; Ma P
    HIV Med; 2022 Mar; 23 Suppl 1():84-94. PubMed ID: 35293099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of the Clinical Pharmacist in the Management of People Living with HIV in the Modern Antiretroviral Era.
    Hill LA; Ballard C; Cachay ER
    AIDS Rev; 2019; 21(4):195-210. PubMed ID: 31834321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristics and short- and long-term direct medical costs among adults with timely and delayed presentation for HIV care in the Netherlands.
    Popping S; Versteegh L; Nichols BE; van de Vijver DAMC; van Sighem A; Reiss P; Geerlings S; Boucher CAB; Verbon A;
    PLoS One; 2023; 18(2):e0280877. PubMed ID: 36753495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors associated with incidence of stroke and heart failure among people living with HIV in Ghana: Evaluating Vascular Event Risk while on Long-Term Antiretroviral Suppressive Therapy (EVERLAST) Study.
    Sarfo FS; Norman B; Appiah L; Ovbiagele B
    J Clin Hypertens (Greenwich); 2021 Jun; 23(6):1252-1259. PubMed ID: 33939257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis.
    Shah ASV; Stelzle D; Lee KK; Beck EJ; Alam S; Clifford S; Longenecker CT; Strachan F; Bagchi S; Whiteley W; Rajagopalan S; Kottilil S; Nair H; Newby DE; McAllister DA; Mills NL
    Circulation; 2018 Sep; 138(11):1100-1112. PubMed ID: 29967196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.
    Ross J; Ingabire C; Umwiza F; Gasana J; Munyaneza A; Murenzi G; Nsanzimana S; Remera E; Akiyama MJ; Anastos KM; Adedimeji A
    PLoS One; 2021; 16(5):e0251645. PubMed ID: 33984044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year Study.
    Kapelios CJ; Argyris AA; Protogerou AD; Katsarolis I; Arida A; Papadopoulou M; Ntaroutsou E; Kitas G; Sfikakis PP; Psichogiou M
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):504-512. PubMed ID: 31923089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.